Literature DB >> 16181085

Axonal ionic pathophysiology in human peripheral neuropathy and motor neuron disease.

Satoshi Kuwabara1, Sonoko Misawa.   

Abstract

Testing the excitability of axons can provide insights into the ionic mechanisms underlying the pathophysiology of axonal dysfunction in human neuropathies and motor neuron diseases. Threshold tracking, which was developed in the 1990's, non-invasively measures a number of axonal excitability indices, which depend on membrane potential and on the Na+ and K+ conductances. This paper reviews recent advances in ionic-pathophysiological studies in human subjects in vivo. Membrane potential of human axons can be estimated, because most of the ion channels expressed on the axolemma are voltage-dependent, and patterns of changes in multiple excitability indices can suggest whether axons are depolarized or hyperpolarized. This has been clearly demonstrated in a single patient with acute hypokalemia (hyperpolarization) and patients with chronic renal failure (depolarization due to hyperkalemia). Muscle cramps/fasciculations arise from hyperexcitability of the motor axons. The enhanced excitability can result from altered ion channel function; an increase in persistent Na+ conductance, a decrease in accommodative K+ conductance, and focal membrane depolarization, all of which increase excitability, have been demonstrated in amyotrophic lateral sclerosis or other disorders affecting lower motor neurons. Patients with demyelinating neuropathy often complain of muscle fatigue. During voluntary contraction, the activation of the electrogenic Na+-K+ pump and resulting membrane hyperpolarization can cause activity-dependent conduction block when the safety factor for impulse transmission is critically reduced. Studies of ion-channel pathophysiology in human subjects have recently begun. Investigating ionic mechanisms is of clinical relevance, because once a specific ionic conductance is identified, blocking or activating it may provide a new therapeutic option for a variety of neuromuscular diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16181085     DOI: 10.2174/1567202043362162

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  4 in total

1.  Severity of Demyelinating and Axonal Neuropathy Mouse Models Is Modified by Genes Affecting Structure and Function of Peripheral Nodes.

Authors:  Kathryn H Morelli; Kevin L Seburn; David G Schroeder; Emily L Spaulding; Loiuse A Dionne; Gregory A Cox; Robert W Burgess
Journal:  Cell Rep       Date:  2017-03-28       Impact factor: 9.423

2.  Peripheral nerve axon involvement in myotonic dystrophy type 1, measured using the automated nerve excitability test.

Authors:  Jong Seok Bae; Sang Gin Kim; Jeong Cheol Lim; Eun Joo Chung; Oeung Kyu Kim
Journal:  J Clin Neurol       Date:  2011-06-28       Impact factor: 3.077

3.  Excitability properties of motor axons in adults with cerebral palsy.

Authors:  Cliff S Klein; Ping Zhou; Christina Marciniak
Journal:  Front Hum Neurosci       Date:  2015-06-03       Impact factor: 3.169

4.  Characterization of Fasciculation Potentials (FPs) in Amyotrophic Lateral Sclerosis (ALS) and Peripheral Nerve Hyperexcitability Syndromes (PNH).

Authors:  Hua Wang; Bin Liu; Jiyou Tang
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.